<DOC>
	<DOCNO>NCT01807000</DOCNO>
	<brief_summary>Phase I study evaluate excretion radioactivity , metabolic profile , pharmacokinetics , safety tolerability follow single oral administration [ 14C ] Prucalopride Succinate healthy male volunteer age 18 50 year ( inclusive ) .The purpose study investigate quickly Prucalopride Succinate break product excrete analyse blood , faeces urine sample collect study .</brief_summary>
	<brief_title>Absorption , Metabolism Excretion ( AME ) Single Dose Radiolabeled Prucalopride Succinate Volunteers</brief_title>
	<detailed_description />
	<criteria>Males age 18 50 year , inclusive Body mass index ( BMI ) ≥18 ≤30 kg/m2 No 2 bowel movement per day few 3 bowel movement per week Provision sign date , write informed consent prior study specific procedure Have participate [ 14C ] study within last 6 month . Exposure clinically significant radiation within 12 month prior dose ( example , serial Xray compute tomography scan , barium meal , current employment job require radiation exposure monitoring ) . Male subject consume 21 unit alcohol per week 3 unit per day .</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>August 2014</verification_date>
</DOC>